| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 9, Issue 5 367-380, Copyright © 1998 by American Association of Cancer Research
ARTICLES |
KK Lu, AV Bazarov, LS Yoon and JM Sedivy
Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, Rhode Island 02912, USA.
The c-Raf-1 kinase is converted into an oncoprotein by functional inactivation of its NH2-terminal regulatory domain and into a dominant-interfering protein by mutations that eliminate catalytic activity. This report describes a systematic charged residue-to-alanine scanning mutagenesis of the ATP-binding subdomain of the c-raf-1 gene. Two temperature-sensitive mutations were found, which were then used to construct both conditionally active and conditionally dominant-defective alleles. Stable cell lines overexpressing both types of mutants were isolated, and their phenotypes were examined. Ectopic expression of Raf-1 activity in quiescent cells was not sufficient to elicit S-phase entry, but the Raf signal could be efficiently complemented by the progression factor insulin-like growth factor I. The results point to a function of Raf-1 in the platelet-derived growth factor and epidermal growth factor pathways, leading to the establishment of competence for cell cycle entry. Ectopic expression of the dominant-defective activity in quiescent cells efficiently blocked entry into S phase. Effects of the dominant-defective protein could be detected minutes after the shift to the restrictive conditions and resulted in the rapid down-regulation of the mitogen-activated protein kinase pathway. Taken together, the phenotypes of the conditionally active and conditionally dominant-defective mutants point to a critical function of Raf-1 at very early times during exit from G0 and entry into G1.
This article has been cited by other articles:
![]() |
S. Ghosh, S. Moore, R. M. Bell, and M. Dush Functional Analysis of a Phosphatidic Acid Binding Domain in Human Raf-1 Kinase: MUTATIONS IN THE PHOSPHATIDATE BINDING DOMAIN LEAD TO TAIL AND TRUNK ABNORMALITIES IN DEVELOPING ZEBRAFISH EMBRYOS J. Biol. Chem., November 14, 2003; 278(46): 45690 - 45696. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Obaya, I. Kotenko, M. D. Cole, and J. M. Sedivy The Proto-oncogene c-myc Acts through the Cyclin-dependent Kinase (Cdk) Inhibitor p27Kip1 to Facilitate the Activation of Cdk4/6 and Early G1 Phase Progression J. Biol. Chem., August 16, 2002; 277(34): 31263 - 31269. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wei, R. M. Hemmer, and J. M. Sedivy Role of p14ARF in Replicative and Induced Senescence of Human Fibroblasts Mol. Cell. Biol., October 15, 2001; 21(20): 6748 - 6757. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adachi, A. J. Obaya, Z. Han, N. Ramos-Desimone, J. H. Wyche, and J. M. Sedivy c-Myc Is Necessary for DNA Damage-Induced Apoptosis in the G2 Phase of the Cell Cycle Mol. Cell. Biol., August 1, 2001; 21(15): 4929 - 4937. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Rizzo, K. Shome, S. C. Watkins, and G. Romero The Recruitment of Raf-1 to Membranes Is Mediated by Direct Interaction with Phosphatidic Acid and Is Independent of Association with Ras J. Biol. Chem., July 28, 2000; 275(31): 23911 - 23918. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |